aTYR PHARMA INC Debt Securities, Available-for-sale
aTYR PHARMA INC (ATYR) had Debt Securities, Available-for-sale of $41.26 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale $41.26M.
- 2026-03-31: Debt Securities, Available-for-sale $56.51M.
- 2025-12-31: Debt Securities, Available-for-sale $67.94M.
- 2025-09-30: Debt Securities, Available-for-sale $84.05M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $41.26M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $56.51M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $67.94M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $84.05M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $63.13M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $65.99M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $61.07M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $54.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $71.68M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $77.69M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $75.62M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $92.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $96.27M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $93.69M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $56.16M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $59.02M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $80.07M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $90.34M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $105.58M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $56.61M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $41.87M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $38.05M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $14.74M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $18.00M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $19.80M 10-Q · filed 2020-08-13 | |
| 2019-12-31 | $21.93M 10-K · filed 2021-03-24 | $21.90M 10-K · filed 2020-03-26 |
| 2018-12-31 | $26.60M 10-K · filed 2020-03-26 | |
| 2017-12-31 | $64.00M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |